CHG

551

+3.18%↑

CHG

551

+3.18%↑

CHG

551

+3.18%↑

CHG

551

+3.18%↑

CHG

551

+3.18%↑

Search

Halma PLC

Închisă

SectorSectorul industrial

3,668

Rezumat

Modificarea prețului

24h

Curent

Minim

3656

Maxim

3702

Indicatori cheie

By Trading Economics

Venit

107M

187M

Vânzări

651M

1.2B

P/E

Medie Sector

39.077

41.244

EPS

0.553

Randament dividend

0.68

Marjă de profit

15.096

Angajați

9,000

EBITDA

184M

317M

Recomandări

By TipRanks

Recomandări

Cumpărare

Prognoză pe 12 luni

+0.91% upside

Dividende

By Dow Jones

Randament dividend

Medie Sector

0.68%

2.18%

Data viitoare de dividende

30 ian. 2026

Statistici piață

By TradingEconomics

Capitalizare de piață

-363M

13B

Deschiderea anterioară

3668

Închiderea anterioară

3668

Sentimentul știrilor

By Acuity

34%

66%

124 / 454 Clasament în Industrials

Halma PLC Grafic

Performanțele din trecut nu reprezintă un indicator fiabil al rezultatelor viitoare.

Știri relevante

12 ian. 2026, 23:54 UTC

Market Talk

CBA Could Underperform Again in 2026 -- Market Talk

12 ian. 2026, 23:48 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 ian. 2026, 23:48 UTC

Market Talk

Nikkei May Rise on Weaker Yen -- Market Talk

12 ian. 2026, 23:43 UTC

Market Talk

Gold Edges Lower on Likely Technical Correction -- Market Talk

12 ian. 2026, 23:18 UTC

Achiziții, Fuziuni, Preluări

Paramount Sues Warner Bros., Plans Proxy Fight. The Ellisons Aren't Giving Up. -- Barrons.com

12 ian. 2026, 21:56 UTC

Market Talk

Light & Wonder Gets Positive Outcome From Lawsuit -- Market Talk

12 ian. 2026, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 ian. 2026, 21:50 UTC

Market Talk

Health Care Roundup: Market Talk

12 ian. 2026, 21:50 UTC

Market Talk
Câștiguri

Auto & Transport Roundup: Market Talk

12 ian. 2026, 21:18 UTC

Market Talk

Global Equities Roundup: Market Talk

12 ian. 2026, 21:18 UTC

Market Talk

Pfizer CEO Sees Large Cash Market for Obesity Drugs -- Market Talk

12 ian. 2026, 20:54 UTC

Câștiguri

Gap, Fortinet, and More Stocks That Usually Outperform After Earnings -- Barrons.com

12 ian. 2026, 20:48 UTC

Market Talk

Oil Futures Settle Higher in Choppy Trade -- Market Talk

12 ian. 2026, 20:33 UTC

Market Talk

U.S. Natural Gas Jumps on Colder Weather Outlook -- Market Talk

12 ian. 2026, 20:18 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole Sees Banco BPM Stake Helping 2025 Net by EUR200M >ACA.FR

12 ian. 2026, 20:18 UTC

Achiziții, Fuziuni, Preluări

Credit Agricole: European Central Bank Approves Crossing of 20% Threshold in Share Capital of Banco BPM

12 ian. 2026, 19:39 UTC

Market Talk

J&J CEO: Trump Pact Allows Company to Focus on Core Operations -- Market Talk

12 ian. 2026, 19:36 UTC

Market Talk

Gold and Silver Set New Records on Fed Probe -- Market Talk

12 ian. 2026, 19:36 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

12 ian. 2026, 19:33 UTC

Market Talk

Venezuela's 'Proven' Oil Reserves Raises Questions -- Market Talk

12 ian. 2026, 19:24 UTC

Achiziții, Fuziuni, Preluări

Dynavax: 'Party A' CEO Sent a Non-Binding $15/Shr Proposal on Dec. 23

12 ian. 2026, 19:22 UTC

Achiziții, Fuziuni, Preluări

Dynavax Files Tender Offer Recommendation Statement Related to Sanofi Deal, Mentions Talks With 'Party A'

12 ian. 2026, 18:21 UTC

Achiziții, Fuziuni, Preluări

Paramount Plans Proxy Fight to Push Hostile Warner Bid -- 2nd Update

12 ian. 2026, 18:20 UTC

Achiziții, Fuziuni, Preluări

This French Biotech Stock Surged 1,700% in 2025. Eli Lilly Is Taking an Interest. -- Barrons.com

12 ian. 2026, 18:19 UTC

Market Talk

Modest Canadian Economic Impact Seen from Venezuela Changes -- Market Talk

12 ian. 2026, 18:16 UTC

Market Talk
Achiziții, Fuziuni, Preluări

Comcast Could Unlock Value With a Spinoff of NBCUniversal Assets, Analysts Say -- Market Talk

12 ian. 2026, 18:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 ian. 2026, 18:09 UTC

Market Talk

Baidu's Outlook Bodes Well For Shares -- Market Talk

12 ian. 2026, 18:01 UTC

Achiziții, Fuziuni, Preluări

QXO Is Raising Another $1.8 Billion for Its M&A War Chest -- Barrons.com

12 ian. 2026, 18:00 UTC

Market Talk

Canada's 'Breakeven' Employment Recalibrating -- Market Talk

Comparație

Modificare preț

Halma PLC Așteptări

Obiectiv de preț

By TipRanks

0.91% sus

Prognoză pe 12 luni

Medie 3,699.37 GBX  0.91%

Maxim 4,150 GBX

Minim 2,490 GBX

În baza a 12 analiști de pe Wall Street care oferă obiective de preț pe 12 luni pentruHalma PLC - Dist în ultimele 3 luni.

Consens privind evaluarea

By TipRanks

Cumpărare

12 ratings

6

Cumpărare

5

Păstrare

1

Vânzare

Sentiment

By Acuity

124 / 454 Clasament în Sectorul industrial

Sentimentul știrilor

Evidențe de creștere

Volatilitate

Sub medie

Volumul știrilor (RCV)

Sub medie

Date financiare

Cheltuieli de vânzare și administrare

Cheltuieli de exploatare

Profit pre-impozitare

Vânzări

Costul vânzărilor

Profit brut din vânzări

Cheltuieli cu dobânzile pe datorie

EBITDA

Profit operațional

$

Despre Halma PLC

Halma plc, together its subsidiaries, provides technology solutions in the safety, health, and environmental markets in the United States, Mainland Europe, the United Kingdom, the Asia Pacific, Africa, the Middle East, and internationally. It operates through three segments: Safety, Environmental & Analysis, and Healthcare. The Safety segment provides products that protect people, assets and infrastructure, and electrical systems which is used in public and commercial spaces and in industrial and logistics operations. This segment serves Fire Safety, Power Safety, Industrial Safety, and Urban Safety markets. The Environmental & Analysis segment offers optical, optoelectronic, and spectral imaging systems; environmental monitoring; analysis of air quality, gases, and water; detection of hazardous gases; and water analysis & treatment systems. It serves the optical analysis, water analysis and treatment, and environmental monitoring markets. The Healthcare segment provides components, devices and systems that provide information and analytics to understand patient health and make decisions across the continuum of care; technologies and solutions to enable in-vitro diagnostic systems and life-science discoveries and development; and technologies that enable treatment across clinical specialties, as well as critical fluidic components used by medical diagnostics and original equipment manufacturers. This segment serves the life sciences, health assessment and analytics, and therapeutic solutions market. The company was incorporated in 1894 and is headquartered in Amersham, the United Kingdom.
help-icon Live chat